tiprankstipranks
ImmuPharma PLC (GB:IMM)
LSE:IMM
UK Market
Want to see GB:IMM full AI Analyst Report?

ImmuPharma (IMM) Financial Statements

30 Followers

ImmuPharma Financial Overview

ImmuPharma's market cap is currently £23.21M. The company's EPS TTM is p0.0001; its P/E ratio is -600.00; ImmuPharma is scheduled to report earnings on May 27, 2026, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue£ 0.00£ 0.00£ 0.00£ 0.00£ 118.35K
Gross Profit£ -35.30K£ -63.88K£ -37.61K£ -118.00K£ 118.35K
Operating Income£ -2.54M£ -2.28M£ -3.06M£ -3.03M£ -6.59M
EBITDA£ -2.51M£ -2.61M£ -3.02M£ -2.91M£ -8.70M
Net Income£ -1.81M£ -2.48M£ -2.92M£ -3.81M£ -8.17M
Balance Sheet
Cash & Short-Term Investments£ 1.35M£ 236.90K£ 208.48K£ 667.81K£ 1.65M
Total Assets£ 1.88M£ 977.01K£ 2.72M£ 3.97M£ 6.00M
Total Debt£ 0.00£ 0.00£ 0.00£ 111.00£ 700.00
Net Debt£ -1.35M£ -236.90K£ -208.48K£ -667.70K£ -1.65M
Total Liabilities£ 1.19M£ 1.52M£ 1.67M£ 1.45M£ 1.58M
Stockholders' Equity£ 686.86K£ -542.86K£ 1.06M£ 2.52M£ 4.41M
Cash Flow
Free Cash Flow£ -2.37M£ -1.77M£ -1.36M£ -2.45M£ -4.88M
Operating Cash Flow£ -2.37M£ -1.77M£ -1.36M£ -2.35M£ -4.83M
Investing Cash Flow£ 6.91K£ 1.29M£ 188.76K£ -77.42K£ -50.28K
Financing Cash Flow£ 3.43M£ 500.02K£ 722.10K£ 1.55M£ 702.05K
Currency in GBP

ImmuPharma Earnings and Revenue History

ImmuPharma Debt to Assets

ImmuPharma Cash Flow

ImmuPharma Forecast EPS vs Actual EPS